Cargando…

Lipoprotein(a) plasma levels are not associated with incident microvascular complications in type 2 diabetes mellitus

AIMS/HYPOTHESIS: Microvascular disease in type 2 diabetes is a significant cause of end-stage renal disease, blindness and peripheral neuropathy. The strict control of known risk factors, e.g. lifestyle, hyperglycaemia, hypertension and dyslipidaemia, reduces the incidence of microvascular complicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Sunny S., Rashid, Mardin, Lieverse, Aloysius G., Kronenberg, Florian, Lamina, Claudia, Mulder, Monique T., de Rijke, Yolanda B., Sijbrands, Eric J. G., van Hoek, Mandy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228906/ https://www.ncbi.nlm.nih.gov/pubmed/32152647 http://dx.doi.org/10.1007/s00125-020-05120-9

Ejemplares similares

Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study
por: Singh, Sunny S., et al.
Publicado: (2020)

The effect of guideline revisions on vascular complications of type 2 diabetes
por: Heijmans, Ralph, et al.
Publicado: (2019)

Association of the IgG N-glycome with the course of kidney function in type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes
por: van Herpt, Thijs T. W., et al.
Publicado: (2017)

Lipoprotein(a) is associated with a larger systemic burden of arterial calcification
por: Singh, Sunny S, et al.
Publicado: (2023)

Lipoprotein(a) is robustly associated with aortic valve calcium
por: Kaiser, Yannick, et al.
Publicado: (2021)

Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification( )
por: Kaiser, Yannick, et al.
Publicado: (2022)

Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria
por: van Herpt, Thijs T W, et al.
Publicado: (2020)

Is High-Density Lipoprotein Cholesterol Causally Related to Kidney Function?: Evidence From Genetic Epidemiological Studies
por: Coassin, Stefan, et al.
Publicado: (2016)

Breakfast partly restores the anti-inflammatory function of high-density lipoproteins from patients with type 2 diabetes mellitus
por: Lemmers, R.F.H., et al.
Publicado: (2021)

Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

Apolipoprotein-CIII O-Glycosylation, a Link between GALNT2 and Plasma Lipids
por: Naber, Annemieke, et al.
Publicado: (2023)

Use of monomeric and oligomeric flavanols in the dietary management of patients with type 2 diabetes mellitus and microalbuminuria (FLAVA trial): study protocol for a randomized controlled trial
por: Rashid, Mardin, et al.
Publicado: (2018)

Lipoprotein(a) and SARS‐CoV‐2 infections: Susceptibility to infections, ischemic heart disease and thromboembolic events
por: Di Maio, Silvia, et al.
Publicado: (2021)

Lipoprotein(a) and SARS-CoV-2 infections: Risk for ischemic heart disease and thromboembolic events
por: Di Maio, S., et al.
Publicado: (2022)

Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes
por: Memarian, Elham, et al.
Publicado: (2021)

Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes
por: Berk, Kirsten A., et al.
Publicado: (2017)

Serum fructosamine, serum glycated albumin and serum glycated β-lipoprotein in type 2 diabetes mellitus patients with and without microvascular complications
por: Kalaria, Tejaskumar R., et al.
Publicado: (2016)

ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study
por: de Vries, Paul S., et al.
Publicado: (2016)

Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
por: Kronenberg, Florian
Publicado: (2016)

Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons
por: van Hoek, M., et al.
Publicado: (2011)

The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A
por: Grüneis, Rebecca, et al.
Publicado: (2022)

Genetic Factors Explain a Major Fraction of the 50% Lower Lipoprotein(a) Concentrations in Finns
por: Erhart, Gertraud, et al.
Publicado: (2018)

Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts
por: Laschkolnig, Anja, et al.
Publicado: (2014)

Microvascular Complications in Adolescents with Type 1 Diabetes Mellitus
por: Demirel, Fatma, et al.
Publicado: (2013)

Preventing microvascular complications in type 1 diabetes mellitus
por: Viswanathan, Vijay
Publicado: (2015)

Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene
por: Coassin, Stefan, et al.
Publicado: (2022)

Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease
por: Schachtl-Riess, Johanna F., et al.
Publicado: (2021)

Evaluating the Causal Relation of ApoA-IV with Disease-Related Traits - A Bidirectional Two-sample Mendelian Randomization Study
por: Mack, Salome, et al.
Publicado: (2017)

The Association of Mid-Regional Pro-Adrenomedullin and Mid-Regional Pro-Atrial Natriuretic Peptide with Mortality in an Incident Dialysis Cohort
por: Gouya, Ghazaleh, et al.
Publicado: (2011)

Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus
por: khazaei, Majid
Publicado: (2011)

Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus
por: Azenabor, Alfred, et al.
Publicado: (2011)

Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus
por: Kaze, Arnaud D., et al.
Publicado: (2021)

Endothelial Dysfunction and Microvascular Complications in Type 1 Diabetes Mellitus
por: Jin, Seon Mi, et al.
Publicado: (2008)

Anemia and Microvascular Complications in Patients With Type 2 Diabetes Mellitus
por: Hosseini, Mahboobeh Sadat, et al.
Publicado: (2014)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chauhan, Anubhav, et al.
Publicado: (2016)

Determinants and Stratification of Microvascular Complications of Type 2 Diabetes Mellitus
por: Reddy Mallimala, Priya, et al.
Publicado: (2023)

Genetic Variant in the IGF2BP2 Gene May Interact With Fetal Malnutrition to Affect Glucose Metabolism
por: van Hoek, Mandy, et al.
Publicado: (2009)

Lipoprotein(a) and incident type-2 diabetes: results from the prospective Bruneck study and a meta-analysis of published literature
por: Paige, Ellie, et al.
Publicado: (2017)

Association of HbA1c Values with Mortality and Cardiovascular Events in Diabetic Dialysis Patients. The INVOR Study and Review of the Literature
por: Sturm, Gisela, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lrr9ij4kgu5mofgdp9ooo7mnd3